Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-26 Purchase | 2024-11-27 5:09 pm | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO | 88,850 | $1.9625 | $174,364 | 1,199,143 (Indirect) | View |
| 2023-09-28 Purchase | 2023-09-28 4:32 pm | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 8,000 | $1.87 | $14,960 | 818,532 (Direct) | View |
| 2023-09-27 Purchase | 2023-09-27 6:37 pm | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 2,500 | $1.87 | $4,675 | 226,937 (Direct) | View |
| 2023-09-27 Purchase | 2023-09-27 6:36 pm | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 6,426 | $1.8468 | $11,868 | 810,532 (Direct) | View |
| 2023-09-25 Purchase | 2023-09-25 5:05 pm | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 5,000 | $1.77 | $8,850 | 224,437 (Direct) | View |
| 2023-09-25 Purchase | 2023-09-25 5:04 pm | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 12,000 | $1.6703 | $20,044 | 804,106 (Direct) | View |
| 2023-09-22 Purchase | 2023-09-22 7:35 pm | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 2,500 | $1.7397 | $4,349 | 219,437 (Direct) | View |
| 2023-09-22 Purchase | 2023-09-22 7:34 pm | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 5,000 | $1.739 | $8,695 | 792,106 (Direct) | View |
| 2023-09-14 Sale | 2023-09-18 7:03 pm | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 8,641 | $2.1017 | $18,161 | 2,403,882 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 8:16 pm | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 27,917 | $2.2675 | $63,301 | 2,412,523 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-10 Option Award | 2024-06-10 5:31 pm | N/A 2034-06-10 | Pyxis Oncology Inc. | PYXS | Metzger Michael A Director | 70,683 | $0 | 70,683 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-07 5:00 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Palani Santhosh Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO & COO | 328,710 | $0 | 1,110,293 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A 2034-03-26 | Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer | 1,071,242 | $3.83 | 1,071,242 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director | 35,219 | $0 | 413,015 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:33 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 35,219 | $0 | 251,405 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director | 35,219 | $0 | 241,405 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Dupont Jakob Director | 38,741 | $0 | 38,741 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 38,741 | $0 | 96,805 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:32 pm | N/A 2034-03-26 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 44,024 | $3.83 | 44,024 (Direct) | View |
| 2024-03-26 Option Award | 2024-03-28 4:31 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra SVP, Chief Accounting Officer | 131,484 | $0 | 398,421 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-13 4:54 pm | N/A 2034-03-12 | Pyxis Oncology Inc. | PYXS | Palani Santhosh Director | 69,760 | $0 | 69,760 (Direct) | View |
| 2023-12-29 Option Award | 2023-12-29 4:33 pm | N/A 2033-12-29 | Pyxis Oncology Inc. | PYXS | Kobayashi Ken Chief Medical Officer | 554,392 | $0 | 554,392 (Direct) | View |
| 2023-11-29 Tax Withholding | 2023-11-30 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 36,949 | $1.4 | 781,583 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-17 4:16 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 40,000 | $0 | 266,937 (Direct) | View |
| 2023-09-22 Option Award | 2023-09-26 7:04 pm | N/A 2033-09-22 | Pyxis Oncology Inc. | PYXS | Dupont Jakob Director | 392,461 | $0 | 392,461 (Direct) | View |
| 2023-09-13 Tax Withholding | 2023-09-13 8:16 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 184,742 | $2.13 | 2,412,523 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 5:02 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO | 187,793 | $0 | 782,106 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 5:01 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 93,896 | $0 | 211,937 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 5:00 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 469,483 | $0 | 2,625,182 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-25 5:30 pm | N/A 2030-09-01 | Pyxis Oncology Inc. | PYXS | Dupont Jakob Director | 26,663 | $0 | 26,663 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:48 pm | N/A 2031-03-30 | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 1,755,665 | $0 | 3,207,985 (Direct) | View |
| 2023-03-24 Disposition | 2023-03-28 4:48 pm | N/A 2031-03-30 | Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO | 1,052,286 | $0 | 3,207,985 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:47 pm | N/A 2031-07-30 | Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO and COO | 542,372 | $0 | 926,882 (Direct) | View |
| 2023-03-24 Disposition | 2023-03-28 4:47 pm | N/A 2031-07-30 | Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO and COO | 332,569 | $0 | 926,882 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:45 pm | N/A 2031-09-12 | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 384,577 | $0 | 905,119 (Direct) | View |
| 2023-03-24 Disposition | 2023-03-28 4:45 pm | N/A 2031-09-12 | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 174,774 | $0 | 905,119 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:45 pm | N/A 2031-07-30 | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 231,650 | $0 | 245,905 (Direct) | View |
| 2023-03-24 Disposition | 2023-03-28 4:45 pm | N/A 2031-07-30 | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer | 157,257 | $0 | 245,905 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:44 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director | 139,355 | $0 | 206,186 (Direct) | View |
| 2023-03-24 Option Award | 2023-03-28 4:43 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 58,064 | $0 | 58,064 (Direct) | View |